These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26535159)

  • 1. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration.
    Yu J; Cilfone NA; Large EM; Sarkar U; Wishnok JS; Tannenbaum SR; Hughes DJ; Lauffenburger DA; Griffith LG; Stokes CL; Cirit M
    CPT Pharmacometrics Syst Pharmacol; 2015 Oct; 4(10):585-94. PubMed ID: 26535159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies.
    Tsamandouras N; Chen WLK; Edington CD; Stokes CL; Griffith LG; Cirit M
    AAPS J; 2017 Sep; 19(5):1499-1512. PubMed ID: 28752430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
    Edington CD; Chen WLK; Geishecker E; Kassis T; Soenksen LR; Bhushan BM; Freake D; Kirschner J; Maass C; Tsamandouras N; Valdez J; Cook CD; Parent T; Snyder S; Yu J; Suter E; Shockley M; Velazquez J; Velazquez JJ; Stockdale L; Papps JP; Lee I; Vann N; Gamboa M; LaBarge ME; Zhong Z; Wang X; Boyer LA; Lauffenburger DA; Carrier RL; Communal C; Tannenbaum SR; Stokes CL; Hughes DJ; Rohatgi G; Trumper DL; Cirit M; Griffith LG
    Sci Rep; 2018 Mar; 8(1):4530. PubMed ID: 29540740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies.
    Maass C; Dallas M; LaBarge ME; Shockley M; Valdez J; Geishecker E; Stokes CL; Griffith LG; Cirit M
    Sci Rep; 2018 May; 8(1):8015. PubMed ID: 29789564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).
    Maass C; Stokes CL; Griffith LG; Cirit M
    Integr Biol (Camb); 2017 Apr; 9(4):290-302. PubMed ID: 28267162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
    Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
    Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for using mathematical modeling approaches to design and interpret multi-organ microphysiological systems (MPS).
    Sung JH; Wang Y; Shuler ML
    APL Bioeng; 2019 Jun; 3(2):021501. PubMed ID: 31263796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing the impact of microphysiological systems with in vitro-in vivo translation.
    Cirit M; Stokes CL
    Lab Chip; 2018 Jun; 18(13):1831-1837. PubMed ID: 29863727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-pharmacokinetic/pharmacodynamic relationships.
    Mager DE
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of microphysiological systems for nonclinical evaluation of cell therapies.
    Candarlioglu PL; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan KA; Fellows MD; Pointon A; Kojala K
    ALTEX; 2024; 41(3):469-484. PubMed ID: 38746991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of the microphysiology systems database for experimental ADME-Tox and disease models.
    Schurdak M; Vernetti L; Bergenthal L; Wolter QK; Shun TY; Karcher S; Taylor DL; Gough A
    Lab Chip; 2020 Apr; 20(8):1472-1492. PubMed ID: 32211684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived Microphysiological Systems for Precision Medicine.
    Ko J; Song J; Choi N; Kim HN
    Adv Healthc Mater; 2024 Mar; 13(7):e2303161. PubMed ID: 38010253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research.
    Casas B; Vilén L; Bauer S; Kanebratt KP; Wennberg Huldt C; Magnusson L; Marx U; Andersson TB; Gennemark P; Cedersund G
    PLoS Comput Biol; 2022 Oct; 18(10):e1010587. PubMed ID: 36260620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity.
    Ait-Oudhia S; Ovacik MA; Mager DE
    MAbs; 2017 Jan; 9(1):15-28. PubMed ID: 27661132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.
    Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE
    Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.
    Zhou Z; Zhu J; Jiang M; Sang L; Hao K; He H
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.